Ion Channel Innovations licensing - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

A smart-glasses engineering workspace reflects Magic Leap’s 269 planned job cuts as the augmented reality pioneer exits first-party devices and pivots towards supplying waveguides and optical technology for artificial intelligence glasses. Representative image.

Magic Leap layoffs rise to 269 as augmented reality pioneer abandons first-party devices

Representative image showing large-scale iron ore mining operations, reflecting investor focus on Rio Tinto plc’s capital intensity, iron ore margins, and balance-sheet pressures following its 2025 results and share price decline.

Fortescue (ASX: FMG) shares fall as $525m Iron Bridge impairment overshadows record shipments

CBIZ to be taken private by Grant Thornton in largest US accounting M&A in 25+ years

Saudi Arabia unveils 14-country maritime coalition to protect Red Sea shipping

Read More

Pharma Industry News

Urovant Sciences acquires licensing for hMaxi-K gene therapy to treat overactive bladder from Ion Channel

Urovant Sciences has secured global licensing rights from Ion Channel Innovations for the development and commercialization of a…

bypharmanewsdaily

August 29, 2018

web analytics